|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Phenazone (antipyrin) & its derivs. | | | | $3,000 | $661,000 | $34,000 | $518,000 |
| Heterocyclic comps. cont. an unfused pyrazole ring (whether or not hydrogen ... | $2,923,000 | $4,488,000 | $3,117,000 | $3,492,000 | $1,011,000 | $1,812,000 | $190,000 |
| Hydantoin & its derivs. | $7,446,000 | $7,842,000 | $7,572,000 | $7,657,000 | $830,000 | $1,115,000 | $5,167,000 |
| Heterocyclic comps. cont. an unfused imidazole ring (whether or not hydroge ... | $22,373,000 | $27,208,000 | $14,702,000 | $9,859,000 | $8,974,000 | $6,468,000 | $10,584,000 |
| Pyridine & its salts | | $14,000 | $152,000 | $13,000 | $12,000 | $28,000 | $163,000 |
| Heterocyclic comps. cont. an unfused pyridine ring (whether or not hydrogen ... | $19,019,000 | $17,664,000 | $18,123,000 | $33,983,000 | $25,393,000 | $40,592,000 | $44,279,000 |
| Heterocyclic comps. cont. a pyrimidine ring (whether or not hydrogenated)/p ... | $41,969,000 | $34,807,000 | $54,065,000 | $72,299,000 | $80,117,000 | $87,240,000 | $74,237,000 |
| Melamine | $3,000 | | | | | | $354,000 |
| Heterocyclic comps. cont. an unfused triazine ring (whether or not hydrogen ... | $26,162,000 | $26,391,000 | $28,004,000 | $44,017,000 | $39,351,000 | $50,033,000 | $48,552,000 |
| Lactams (excl. of 2933.71 & 2933.72) | $2,341,000 | $843,000 | $3,243,000 | $2,701,000 | $3,301,000 | $4,042,000 | $5,837,000 |
| Total | $122,236,000 | $119,257,000 | $128,978,000 | $174,024,000 | $159,650,000 | $191,364,000 | $189,881,000 |
|
|
